Prevalence and Factors Affecting the Use of Antipsychotics and Antipsychotic Polypharmacy in a Child and Adolescent Psychiatry Inpatient Service
Journal of Child and Adolescent Psychopharmacology · 2023
DOI: 10.1089/cap.2022.0065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, 2023. Verfasst von Ahmet Büber und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, Faculty of Medicine, Pamukkale University, Denizli, Türkiye. Hauptthemen laut MEDLINE: Antipsychotic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Themen: Medikationssicherheit
Abstract (Originalsprache)
Objective
We aimed to examine the antipsychotics used by patients hospitalized in the child and youth inpatient service providing tertiary care to investigate whether there is a difference between admission and discharge, polypharmacy, which antipsychotics are used, and which psychotropics are used concomitant with antipsychotics.
Methods
Research data were collected retrospectively from all children and adolescents hospitalized in a child and adolescent psychiatry inpatient service in a university hospital in a 4-year period (2015–2019). The sociodemographic and clinical characteristics of the patients, the antipsychotics they used at admission and discharge, the other psychotropics concomitantly used with antipsychotics, and the side effects associated with antipsychotics during hospitalization were collected from the files of the 363 patients.
Results
Patients on antipsychotics increased 12.1% from hospitalization to discharge. Antipsychotic polypharmacy increased from 16.2% at admission to 30.7% at discharge. Logistic regression analysis was performed to investigate the factors affecting antipsychotic and antipsychotic polypharmacy. Self-harm, aggression/violence, and extended hospitalization were factors associated with increased antipsychotic use. Psychotic symptoms, psychotic disorder, and extended hospitalization were factors associated with an increase in antipsychotic polypharmacy.
Conclusions
Understanding the factors that may cause antipsychotic use and polypharmacy in inpatient services in children and adolescents may prevent unnecessary drug use and long-term side effects that may occur due to these drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Child and Adolescent Psychiatry, Faculty of Medicine, Pamukkale University, Denizli, Türkiye.
- Department of Child and Adolescent Psychiatry, Kırıkkale Yüksek Ihtisas Hospital, Kırıkkale, Türkiye.
- Department of Biostatistics, Faculty of Medicine, Pamukkale University, Denizli, Türkiye.
ORCID-Profile: Ahmet Büber, Erdal Görkem Gavcar
Zitieren
APA
Büber, A., Gavcar, E. G., Başay, Ö., Ünlü, G., Kabukçu Başay, B., & Şenol, H. (2023). Prevalence and Factors Affecting the Use of Antipsychotics and Antipsychotic Polypharmacy in a Child and Adolescent Psychiatry Inpatient Service. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2022.0065
Vancouver
Büber A, Gavcar EG, Başay Ö, Ünlü G, Kabukçu Başay B, Şenol H. Prevalence and Factors Affecting the Use of Antipsychotics and Antipsychotic Polypharmacy in a Child and Adolescent Psychiatry Inpatient Service. Journal of Child and Adolescent Psychopharmacology. 2023. doi:10.1089/cap.2022.0065
BibTeX
@article{Bber2023,
author = {Büber, Ahmet and Gavcar, Erdal Görkem and Başay, Ömer and Ünlü, Gülşen and Kabukçu Başay, Bürge and Şenol, Hande},
title = {Prevalence and Factors Affecting the Use of Antipsychotics and Antipsychotic Polypharmacy in a Child and Adolescent Psychiatry Inpatient Service},
journal = {Journal of Child and Adolescent Psychopharmacology},
year = {2023},
doi = {10.1089/cap.2022.0065}
}
EUVIMED